Amgen Inc
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly’s weight loss drug dominance
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson | Getty Images Novo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but their duopoly is closer than ever to facing a threat from a new rival. Amgen […]
Read MoreStocks building the biggest moves midday: Apple, Expedia, Block, Dwell Nation and more
Check out out the companies generating headlines in midday buying and selling. Apple — The tech large jumped more than 6% right after saying it would repurchase $110 billion in shares . Apple also posted beats on the major and base traces, reporting fiscal next-quarter earnings at $1.53 for every share on $90.75 billion in […]
Read MoreDow jumps much more than 400 details as weak careers report raises Fed amount slice hopes: Live updates
Shares jumped sharply Friday following a softer-than-expected April jobs report boosted hopes that the Federal Reserve could begin reducing fascination fees soon. The Dow Jones Industrial Normal acquired 420 factors, or 1.1%. The S&P 500 surged 1.1% although the Nasdaq Composite rallied 1.9%. Friday’s nonfarm payrolls report showed 175,000 careers acquired in April, underneath the […]
Read MoreAmgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Pavlo Gonchar | Lightrocket | Getty Images Amgen‘s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new competition in the rapidly growing weight loss drug industry, sending shares of the current obesity players, Novo Nordisk and Eli Lilly, […]
Read MoreShares earning the largest moves premarket: Apple, Amgen, Cloudflare and more
Examine out the companies creating headlines before the bell. Hershey — Shares of the chocolate confectionary maker additional about 1% right after Hershey posted a very first-quarter earnings defeat. The company described altered earnings of $3.07 per share, which came earlier mentioned the $2.76 for each share analysts polled by LSEG experienced predicted. Hershey’s $3.25 […]
Read MoreAmgen scraps experimental weight loss pill, moves forward with injection
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Thursday said it will stop developing its experimental weight loss pill and instead move forward with its injectable drug and other products in development for obesity. The announcement is a setback for […]
Read MoreShares generating the biggest moves after hrs: Apple, Cloudflare, Expedia, Block and additional
Examine out the businesses building headlines in soon after-hrs trading: Apple — The Iphone maker innovative 7% as it announced a $110 billion share repurchase and a best- and bottom-line conquer. Apple’s fiscal next-quarter earnings arrived in at $1.53 per share, although earnings was $90.75 billion. That surpassed analysts’ estimates for earnings of $1.50 per […]
Read MoreInventory futures rise following Fed decides to keep premiums continual: Live updates
Stock futures advanced Wednesday evening as buyers appeared ahead to far more corporate earnings due Thursday and important labor information established for afterwards in the week. Dow Jones Industrial Common futures added 65 details, or .2%. S&P 500 futures climbed .2%. Nasdaq 100 futures improved by .3%. In immediately after-several hours investing, chipmaker Qualcomm rose […]
Read MoreJohnson & Johnson tops quarterly profit estimates as medical device sales jump
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business surged. Meanwhile, the company’s total revenue for the […]
Read MoreAmgen wants in on the booming weight loss drug market — and it's taking a different approach
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company is testing an injectable […]
Read More